Latest content from Pharmetheus.
Our CEO, Peter Milligan, has been interviewed by the Pharma Tech Outlook magazine. Read more about how cutting-edge methods and tools help change the model-informed drug development landscape of the pharmaceutical industry, from early clinical trials to drug approval.
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..